Pfizer-biontech Covid-19 Vaccine
- All
- News
- Videos
-
3 Covid Shots Generate Good Response In Under-5s: Pfizer-BioNTech
The Pfizer-BioNTech Covid-19 vaccine is safe and effective for children aged six months to under five years when given in 3 doses.
-
Pfizer-BioNTech Begin Trials For An Omicron-Specific Vaccine
Pfizer and BioNTech have begun enrollment for a clinical trial to test the safety and immune response of their Omicron-specific Covid-19 vaccine in adults aged up to 55, the companies said in a statement Tuesday.
-
Pfizer Vaccine Cuts Omicron Hospitalisation By 70% In South Africa: Study
Two doses of Pfizer-BioNTech's COVID-19 vaccine appear to have given 70 per cent protection against hospitalisation in South Africa in recent weeks, according to a major real-world study which suggests weaker efficacy against the new Omicron variant.
-
UK Orders 114 Million Additional Covid Jabs Amid 'Omicron' Variant Scare
The UK government said late Wednesday it has ordered 114 million additional Covid-19 vaccine doses, from pharmaceutical giants Pfizer-BioNTech and Moderna, to bolster its jabs drive over the next two years.
-
Iraq Gets 1.2 Million Pfizer Covid Vaccine Doses Amid Fears Of 4th Wave
Iraq said Saturday it has received 1.2 million doses of Pfizer-BioNTech's COVID-19 vaccine through the Covax sharing scheme, amid fears of a fourth wave in the country.
-
Canada Approves Pfizer Covid Vaccine For Children In 5-11 Age Group
Canada on Friday became the latest country to authorize the Pfizer-BioNTech Covid-19 vaccine for children aged between five and 11-years-old, according to an official statement.
-
Pfizer Seeks Approval For Covid Jabs For Children Aged 5-11 In Canada
Pfizer-BioNTech submitted an authorization request to Health Canada on Monday for the use of its Covid-19 vaccine in children aged 5-11, the companies and the Canadian government said.
-
US To Donate 500 Million More Covid Vaccines To Other Countries: Biden
President Joe Biden will announce Wednesday the US plans to donate an additional 500 million Pfizer-BioNTech Covid vaccines to the rest of the world, bringing its total commitment to 1.1 billion, officials said.
-
Pfizer Jab Side Effects In 12-15 Year Olds Mild To Moderate: Study
A new study has revealed that the side effects of the Pfizer-BioNTech jab against COVID-19 in 12-15-year-olds at high risk of complications from the infection are likely to be mild to moderate.
-
Pfizer Jab Effectiveness "Declines Faster" Than AstraZeneca: Oxford Study
The effectiveness of the Pfizer-BioNTech vaccine against Covid-19 declines faster than that of the AstraZeneca jab, according to a new study published on Thursday.
-
Saudi Arabia To Inoculate Those Aged 12 To 18 With Pfizer Vaccine
Saudi Arabia will start inoculating young people aged 12 to 18 against COVID-19 with the Pfizer-BioNtech vaccine after it was approved by the Saudi Food and Drug Authority, the health ministry said on a tweet on Sunday.
-
AstraZeneca, Pfizer Vaccines Effective Against Delta Covid Variants: Study
COVID-19 vaccines made by AstraZeneca and the Pfizer-BioNTech alliance remain broadly effective against Delta and Kappa variants of the COVID-19 causing virus, which were first identified in India, according to a scientific study.
-
US To Buy 500 Million Pfizer Vaccine Doses, Donate Jabs Globally: Report
The administration of President Joe Biden is buying 500 million doses of the Pfizer-BioNTech Covid-19 vaccine to distribute among other countries, US media reported Wednesday citing people familiar with the matter.
-
Pfizer Far Less Effective For Delta Variant Than Earlier Strains: Lancet Study
People who got Pfizer-BioNTech vaccine are likely to have more than 5 times lower levels of neutralising antibodies against Delta variant first identified in India compared to original strain, according to research published in The Lancet journal.
-
Pfizer Says Talks Underway With Centre On Bringing Covid Vaccine To India
To bring Pfizer-BioNTech COVID-19 vaccine for use in India, discussions are underway between the central government and Pfizer Inc.
-
3 Covid Shots Generate Good Response In Under-5s: Pfizer-BioNTech
The Pfizer-BioNTech Covid-19 vaccine is safe and effective for children aged six months to under five years when given in 3 doses.
-
Pfizer-BioNTech Begin Trials For An Omicron-Specific Vaccine
Pfizer and BioNTech have begun enrollment for a clinical trial to test the safety and immune response of their Omicron-specific Covid-19 vaccine in adults aged up to 55, the companies said in a statement Tuesday.
-
Pfizer Vaccine Cuts Omicron Hospitalisation By 70% In South Africa: Study
Two doses of Pfizer-BioNTech's COVID-19 vaccine appear to have given 70 per cent protection against hospitalisation in South Africa in recent weeks, according to a major real-world study which suggests weaker efficacy against the new Omicron variant.
-
UK Orders 114 Million Additional Covid Jabs Amid 'Omicron' Variant Scare
The UK government said late Wednesday it has ordered 114 million additional Covid-19 vaccine doses, from pharmaceutical giants Pfizer-BioNTech and Moderna, to bolster its jabs drive over the next two years.
-
Iraq Gets 1.2 Million Pfizer Covid Vaccine Doses Amid Fears Of 4th Wave
Iraq said Saturday it has received 1.2 million doses of Pfizer-BioNTech's COVID-19 vaccine through the Covax sharing scheme, amid fears of a fourth wave in the country.
-
Canada Approves Pfizer Covid Vaccine For Children In 5-11 Age Group
Canada on Friday became the latest country to authorize the Pfizer-BioNTech Covid-19 vaccine for children aged between five and 11-years-old, according to an official statement.
-
Pfizer Seeks Approval For Covid Jabs For Children Aged 5-11 In Canada
Pfizer-BioNTech submitted an authorization request to Health Canada on Monday for the use of its Covid-19 vaccine in children aged 5-11, the companies and the Canadian government said.
-
US To Donate 500 Million More Covid Vaccines To Other Countries: Biden
President Joe Biden will announce Wednesday the US plans to donate an additional 500 million Pfizer-BioNTech Covid vaccines to the rest of the world, bringing its total commitment to 1.1 billion, officials said.
-
Pfizer Jab Side Effects In 12-15 Year Olds Mild To Moderate: Study
A new study has revealed that the side effects of the Pfizer-BioNTech jab against COVID-19 in 12-15-year-olds at high risk of complications from the infection are likely to be mild to moderate.
-
Pfizer Jab Effectiveness "Declines Faster" Than AstraZeneca: Oxford Study
The effectiveness of the Pfizer-BioNTech vaccine against Covid-19 declines faster than that of the AstraZeneca jab, according to a new study published on Thursday.
-
Saudi Arabia To Inoculate Those Aged 12 To 18 With Pfizer Vaccine
Saudi Arabia will start inoculating young people aged 12 to 18 against COVID-19 with the Pfizer-BioNtech vaccine after it was approved by the Saudi Food and Drug Authority, the health ministry said on a tweet on Sunday.
-
AstraZeneca, Pfizer Vaccines Effective Against Delta Covid Variants: Study
COVID-19 vaccines made by AstraZeneca and the Pfizer-BioNTech alliance remain broadly effective against Delta and Kappa variants of the COVID-19 causing virus, which were first identified in India, according to a scientific study.
-
US To Buy 500 Million Pfizer Vaccine Doses, Donate Jabs Globally: Report
The administration of President Joe Biden is buying 500 million doses of the Pfizer-BioNTech Covid-19 vaccine to distribute among other countries, US media reported Wednesday citing people familiar with the matter.
-
Pfizer Far Less Effective For Delta Variant Than Earlier Strains: Lancet Study
People who got Pfizer-BioNTech vaccine are likely to have more than 5 times lower levels of neutralising antibodies against Delta variant first identified in India compared to original strain, according to research published in The Lancet journal.
-
Pfizer Says Talks Underway With Centre On Bringing Covid Vaccine To India
To bring Pfizer-BioNTech COVID-19 vaccine for use in India, discussions are underway between the central government and Pfizer Inc.
